User menu

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia.

Bibliographic reference Laterre, Pierre-François ; Opal, Steven M ; Abraham, Edward ; LaRosa, Steven P ; Creasey, Abla A ; et. al. A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia.. In: Critical care (London, England), Vol. 13, no. 2, p. R36 (2009)
Permanent URL http://hdl.handle.net/2078.1/26294